Close

Choose your country

Or view all businesses for sale

Worldwide

Advertisement

Listed by:

AcquiTrust Advisors

High-Volume 340B Specialty Pharmacy 700 Rx/Day For Sale

New York, US
Asking Price:
On request Furniture / Fixtures included
Sales Revenue:
$22,593,184
Cash Flow:
$1,588,579

Established in 2004, this premier Florida specialty pharmacy has built a 20-year reputation as a dominant player in the market. Operating out of a sprawling, high-traffic 10,000 sq. ft. facility, the business is a highly oiled machine, consistently dispensing an average of 700 prescriptions every single day.

This is being offered as an exclusive "Two-Package Deal," combining a massive retail/specialty footprint with highly lucrative pharmaceutical contracts and licensing.

Unmatched Revenue Drivers:
What sets this pharmacy apart from standard retail operations are its specialized contracts and licenses, which act as a massive moat against the competition:

The 340B Advantage: The pharmacy holds a highly sought-after 340B contract, allowing for significantly widened profit margins on specialty drugs.

HIV Collaborative Agreement: A newly executed collaborative agreement with a local 340B doctor allows the pharmacy to directly test for and prescribe HIV medications. This is one of the highest-margin sectors in the specialty pharmacy space and offers massive immediate upside for the new owner.

Wholesale License Included: The business holds an active wholesale license, providing an entirely separate, highly profitable B2B revenue channel.

Clean PBM Contracts: The business holds active, clean contracts with all major insurance carriers and PBMs, ensuring a seamless transition of cash flow.

Strategic Synergy & Expansion ("The Poppies Merger"):
Included in the strategic roadmap is a rare opportunity to absorb/merge with a neighboring, complementary business ("Poppies"). Executing this consolidation will immediately slash overhead costs—including rent, payroll, and dual licensing fees—driving the bottom-line net profit even higher.

Operations & Staffing:
The current operation is highly efficient and designed to handle volume. The majority owner is retiring after a highly successful two-decade run, and the minority owner is transitioning out to pursue other ventures. This creates the perfect clean-slate opportunity for an experienced operator, expanding pharmacy group, or healthcare investor to take 100% control of a thriving enterprise.

Key Investment Highlights at a Glance:

Location: Prime Florida Real Estate (10,000 Sq. Ft. Facility)

Volume: 700 Rx / Day consistently

Coveted Contracts: Active 340B Contract & Wholesale License

Growth Catalyst: New HIV testing/prescribing collaborative agreement

History: 20 years of goodwill and an established, loyal patient base

Next Steps:
High-volume 340B specialty pharmacies with wholesale licenses in Florida rarely hit the public market. This will move quickly. Serious buyers must sign an NDA and provide proof of funds to receive the full Confidential Information Memorandum (CIM) and financials.

Contact us today to secure your position!

Property Information

Real Estate:

Lease

Leasehold Rent:

$10,000 per annum

Location:

Located in a high-traffic area, this 10,000 sq. ft. facility dispenses an average of 700 prescriptions daily, offering excellent operational efficiency.

Premises Details:

The transaction includes all going-concern goodwill, PBM contracts, software, licenses, and equipment across ~10,000 sq. ft. of facility space. Saleable inventory (~$3.0M at cost) will be determined via an independent physical count prior to closing.

Size in square feet:
10,000

Business Operation

Management type:
This business is owner operated.
Expansion Potential:

Specialty drugs represent over 50% of total U.S. pharmaceutical spend, driving rapid industry expansion. Paired with a 340B contract pharmacy arrangement and a scarce state wholesale distributor permit, this enterprise holds an impenetrable competitive moat over traditional retail pharmacies.

Competition / Market:

Specialty drugs represent over 50% of total U.S. pharmaceutical spend, driving rapid industry expansion. Paired with a 340B contract pharmacy arrangement and a scarce state wholesale distributor permit, this enterprise holds an impenetrable competitive moat over traditional retail pharmacies.

Reasons for selling:

Retiring and other business interests.

Employees:
17
Years established:
21 years

Other Information

Support & training:

The majority owner is retiring after 50 years in the industry. To guarantee a smooth handover, the minority operating principal—who manages key institutional and vendor accounts—is willing to remain through a defined transition period alongside the loyal 23-person staff.

Furniture / Fixtures value:
$200,000 - included in the asking price
Inventory / Stock value:
$3,000,000